Participating Faculty: Pulmonary Arterial Hypertension: Progress and Challenges in the Modern Treatment Era

This supplement to The American Journal of Managed Care highlights advancements in the management of pulmonary arterial hypertension (PAH) and provides an overview of challenges that remain, including delayed diagnosis, non-standardized clinical trials, and poor medication adherence. Also discussed are future directions in PAH outcomes research.This supplement was sponsored by Actelion Pharmaceuticals US, Inc.

Faculty

Stacy A. Mandras, MD

Director, Pulmonary Hypertension

Section of Cardiomyopathy and Heart Transplantation

Ochsner Medical Center

New Orleans, Louisiana

Robert J. Gilkin, Jr, RPh, MBA

Vice President

Gemini Healthcare, LLC

Westbrook, Connecticut

Janis A. Pruett, EdD, RN, MSN, CDE, FNP-BC

Senior Medical Liaison

US Medical Managed Markets and HEOR

Actelion Pharmaceuticals US, Inc

South San Francisco, California

Susan Raspa, RN, BSN

Senior Medical Liaison

US Medical Managed Markets and HEOR

Actelion Pharmaceuticals US, Inc.

South San Francisco, California

Faculty Disclosures

These faculty report relationships with the following organizations:

Stacy A. Mandras, MD

Consultant/paid advisory board/lecture fees: Actelion Pharmaceuticals US, Inc, and Bayer Pharmaceuticals

Robert J. Gilkin, Jr, RPh, MBA

Consultant: Actelion Pharmaceuticals US, Inc, and Pfizer

Janis A. Pruett, EdD, RN, MSN, CDE, FNP-BC

Employment/stock ownership: Actelion Pharmaceuticals US, Inc

Susan Raspa, RN, BSN

Employment/stock ownership: Actelion Pharmaceuticals US, Inc

Signed disclosures are on file at the office of The American Journal of Managed Care, Plainsboro, New Jersey.

Opinions expressed by authors, contributors, and advertisers are their own and not necessarily those of Clinical Care Targeted Communications, LLC, d/b/a Managed Care & Healthcare Communications, LLC, the editorial staff, or any member of the editorial advisory board. Clinical Care Targeted Communications, LLC, d/b/a Managed Care & Healthcare Communications, LLC, is not responsible for accuracy of dosages given in articles printed herein. The appearance of advertisements in this publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality, or safety. Clinical Care Targeted Communications, LLC, d/b/a Managed Care & Healthcare Communications, LLC, disclaims responsibility for any injury to persons or property resulting from any ideas or products referred to in the articles or advertisements.

Download PDF: Participating Faculty: Pulmonary Arterial Hypertension: Progress and Challenges in the Modern Treatment Era